Your session is about to expire
← Back to Search
Topical Corticosteroid and Retinoid Combination
Duobrii for Scalp Psoriasis
Phase 4
Waitlist Available
Led By Zoe D Draelos, MD
Research Sponsored by Dermatology Consulting Services, PLLC
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
1. Males or non-pregnant females 18+ years of age. 2. Plaque type moderate to severe scalp psoriasis suitable for topical treatment.
3. Subjects must be in general good health as determined from a medical history.
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 12 weeks
Awards & highlights
Summary
This trial tests a special lotion for people with serious scalp psoriasis. The lotion combines two medications to slow skin cell growth and reduce redness and itching. Patients will use it daily for a few months to see if it improves their condition. The lotion being tested combines calcipotriol and betamethasone dipropionate, which have been shown to be effective and well-tolerated in previous studies for treating scalp psoriasis.
Eligible Conditions
- Scalp Psoriasis
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowTimeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ 12 weeks
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~12 weeks
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Hair Growth
Scalp Itch
Trial Design
1Treatment groups
Experimental Treatment
Group I: Active ArmExperimental Treatment1 Intervention
0.045% Tazarotene/0.01% Habetasol Lotion apply once daily at bedtime to the scalp afflicted with psoriasis
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
0.045% Tazarotene/0.01% Halobetasol Lotion
2023
Completed Phase 4
~20
Find a Location
Who is running the clinical trial?
Ortho DermatologicsIndustry Sponsor
4 Previous Clinical Trials
1,201 Total Patients Enrolled
Dermatology Consulting Services, PLLCLead Sponsor
3 Previous Clinical Trials
100 Total Patients Enrolled
Zoe D Draelos, MDPrincipal InvestigatorDermatology Consulting Services, PLLC
6 Previous Clinical Trials
329 Total Patients Enrolled
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:Research Study Groups:
This trial has the following groups:- Group 1: Active Arm
Awards:
This trial has 3 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
- Drug Has Already Been Approved - The FDA has already approved this drug, and is just seeking more data.
- Pivotal Trial - The final step before approval, pivotal trials feature drugs that have already shown basic safety & efficacy.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Other Trials to Consider
Popular Categories
Share this study with friends
Copy Link
Messenger